Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentrix (CNXC) Cash & Equivalents: 2019-2024

Historic Cash & Equivalents for Concentrix (CNXC) over the last 6 years, with Nov 2024 value amounting to $240.6 million.

  • Concentrix's Cash & Equivalents rose 42.24% to $350.3 million in Q3 2025 from the same period last year, while for Aug 2025 it was $350.3 million, marking a year-over-year increase of 42.24%. This contributed to the annual value of $240.6 million for FY2024, which is 18.54% down from last year.
  • Per Concentrix's latest filing, its Cash & Equivalents stood at $240.6 million for FY2024, which was down 18.54% from $295.3 million recorded in FY2023.
  • In the past 5 years, Concentrix's Cash & Equivalents registered a high of $295.3 million during FY2023, and its lowest value of $145.4 million during FY2022.
  • Moreover, its 3-year median value for Cash & Equivalents was $240.6 million (2024), whereas its average is $227.1 million.
  • In the last 5 years, Concentrix's Cash & Equivalents decreased by 20.56% in 2022 and then skyrocketed by 103.14% in 2023.
  • Yearly analysis of 5 years shows Concentrix's Cash & Equivalents stood at $156.4 million in 2020, then increased by 17.05% to $183.0 million in 2021, then dropped by 20.56% to $145.4 million in 2022, then spiked by 103.14% to $295.3 million in 2023, then declined by 18.54% to $240.6 million in 2024.